This podcast was created with support from Boehringer Ingelheim Canada.
Schizophrenia is a complex mental disorder that affects millions worldwide. Though psychosis is the hallmark symptom of this serious mental illness, cognitive impairment is another core feature that significantly impacts patients' daily functioning and quality of life. In this podcast episode, we delve into the critical intersection of schizophrenia and cognitive impairment, exploring its far-reaching effects and the challenges it...
This podcast was created with support from Boehringer Ingelheim Canada.
Schizophrenia is a complex mental disorder that affects millions worldwide. Though psychosis is the hallmark symptom of this serious mental illness, cognitive impairment is another core feature that significantly impacts patients' daily functioning and quality of life. In this podcast episode, we delve into the critical intersection of schizophrenia and cognitive impairment, exploring its far-reaching effects and the challenges it presents for both patients and healthcare providers.
Our expert panel, consisting of Chris Summerville, CEO of the Schizophrenia Society of Canada and Dr. Heather McNeely, Clinical Psychologist and Neuropsychologist in the Schizophrenia and Community Integration Service at St. Joseph’s Healthcare Hamilton explores the various domains of cognition affected, including memory, attention, and executive functioning, and how these impairments manifest in patients' lives.
The conversation also touches on current assessment methods, emerging treatment options, and the importance of addressing cognitive symptoms alongside other aspects of schizophrenia management. Our guests share their perspectives on the challenges faced in clinical practice, ongoing research initiatives, and the potential for cognitive remediation therapies to improve outcomes for individuals with schizophrenia.
This episode aims to raise awareness about the often-overlooked cognitive aspects of schizophrenia, highlight the need for comprehensive care approaches, and discuss strategies for enhancing cognitive function and overall well-being in patients living with this challenging condition.
--
Chris Summerville, D.Min., CPRRP, LL.D (Honorary), Chief Executive Officer, Schizophrenia Society of Canada
Chris has been a prominent advocate in the mental health field for over 30 years, driven by personal experiences with family members who have bipolar disorder, schizophrenia, and depression, and through his own journey with mental health services. Since 2007, he has served as CEO of the Schizophrenia Society of Canada. With a doctorate from Dallas Theological Seminary and certification as a Psychosocial Rehabilitation Recovery Practitioner (CPRRP), Chris also received an honorary Doctor of Laws from Brandon University for his leadership in mental health advocacy.
As a leader and advocate, Chris supports a recovery-oriented, holistic approach to mental health that incorporates bio-psycho-social-spiritual perspectives. His contributions include serving on the Board of Directors of the Mental Health Commission of Canada since 2007, where he has been involved in initiatives like the Hallway Group and the Headstrong Project. Chris has also been active on various boards, including the Mood Disorders Society of Canada and Psychosocial Rehabilitation Canada.
Dr. Heather McNeely Clinical Psychologist and Neuropsychologist in the Schizophrenia and Community Integration Service at St. Joseph’s Healthcare Hamilton
Dr. Heather McNeely is a practicing clinical psychologist and neuropsychologist in the Schizophrenia and Community Integration Service at St. Joseph’s Healthcare Hamilton where she is also Clinical Lead for the Clinical Neuropsychology Service. She is also a Full Professor and Academic Lead of the Schizophrenia Division in the Department of Psychiatry and Behavioural Neurosciences at McMaster University.
In addition to her clinical work, Dr. McNeely is actively involved in teaching, psychology training and research aimed at improving clinical and social outcomes for adults with schizophrenia and related disorders. She has been extensively involved in leading quality improvement initiatives at St. Joseph’s Healthcare, Hamilton, and she has been an invited contributor to provincial and national expert panels on implementation of quality care standards for adults with schizophrenia.
